Favorable clinical outcome of cervical cancers infected with human papilloma virus type 58 and related types
暂无分享,去创建一个
H. Lai | Chien‐An Sun | T. Chu | H C Lai | C A Sun | M H Yu | H J Chen | H S Liu | T Y Chu | Hang‐Seng Liu | M. Yu | Huey‐Jung Chen
[1] V. Defendi,et al. Human papillomavirus type 6b DNA required for initiation but not maintenance of transformation of C127 mouse cells , 1990, Journal of virology.
[2] C. Peyton,et al. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. , 1994, The Journal of infectious diseases.
[3] R Reid,et al. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. , 1992, Obstetrics and gynecology.
[4] M. Tattersall,et al. Papillomavirus DNA and prognosis in cervical cancer , 1991, The Lancet.
[5] F. X. Bosch,et al. The epidemiology of human papillomavirus and cervical cancer. , 1992 .
[6] A. Beckmann,et al. Human papillomavirus types 52 and 58 are prevalent in cervical cancers from Chinese women. , 1997, International journal of cancer.
[7] Chien-Jen Chen,et al. Human papillomavirus types 52 and 58 are prevalent in cervical cancer from Chinese women , 1997, International journal of cancer.
[8] Julian Peto,et al. Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective , 1995 .
[9] E. de Villiers. Heterogeneity of the human papillomavirus group , 1989, Journal of virology.
[10] H. zur Hausen. Human papillomaviruses in the pathogenesis of anogenital cancer. , 1991, Virology.
[11] R. Chaganti,et al. Allelotype analysis of cervical carcinoma. , 1994, Cancer research.
[12] J. Bourhis,et al. Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA , 1990, The Lancet.
[13] H. Klinger,et al. Loss of heterozygosity on chromosome 17p and mutant p53 in HPV-negative cervical carcinomas , 1992, The Lancet.
[14] Y. Taketani,et al. Type of human papillomavirus is related to clinical features of cervical carcinoma , 1996, Cancer.
[15] M. Manos,et al. 42 – DETECTION AND TYPING OF GENITAL HUMAN PAPILLOMAVIRUSES , 1990 .
[16] Chi-An Chen,et al. The genotypes and prognostic significance of human papillomaviruses in cervical cancer , 1994, International journal of cancer.
[17] H. Bernard,et al. Phylogenetic analysis of 48 papillomavirus types and 28 subtypes and variants: a showcase for the molecular evolution of DNA viruses , 1992, Journal of virology.
[18] D. Roder,et al. Increased age and mortality associated with cervical carcinomas negative for human papillomavirus RNA , 1991, The Lancet.
[19] W. Sauerbrei,et al. Human papillomavirus DNA in cervical carcinoma—correlation with clinical data and influence on prognosis , 1994, International journal of cancer.
[20] E. Villiers. Heterogeneity of the human papillomavirus group. , 1989 .
[21] Human papillomavirus types 52 and 58 , 1998, International journal of cancer.
[22] Chien-Jen Chen,et al. Human papillomavirus types 52 and 58 are prevalent in cervical cancers from Chinese women , 1997 .
[23] G. Riou,et al. Somatic deletions and mutations of c-Ha-ras gene in human cervical cancers. , 1988, Oncogene.
[24] H. Hausen. Human papillomaviruses in the pathogenesis of anogenital cancer. , 1991 .
[25] K. Münger,et al. The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A , 1988, Cell.
[26] P. Gariglio,et al. High correlation between molecular alterations of the c-myc oncogene and carcinoma of the uterine cervix. , 1987, Cancer research.
[27] A. Vincent-Salomon,et al. Human papillomavirus genotype as a major determinant of the course of cervical cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] C. Shen,et al. HPV‐associated cervical cancers show frequent allelic loss at 3p14 but no apparent aberration of FHIT mRNA , 1998, International journal of cancer.